Welcure Drugs and Pharmaceuticals has announced a board meeting on December 01 after postponing its previously scheduled meeting due to director unavailability. The board will discuss crucial plans to raise funds, exploring options like equity shares, convertible instruments, preferential allotment, rights issues, QIPs, ADR/GDR, or FCCBs. This decision is vital for the company's financial growth and future operations, allowing it to secure necessary capital.